1
Investors
About
Rejuvenation Technologies develops modified mRNA therapeutics that temporarily activate telomerase to safely lengthen telomeres in human cells, aiming to reverse cellular aging and treat telomere-shortening diseases such as pulmonary fibrosis, liver disease, and bone marrow failure.
Explore Rejuvenation Technologies Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.